Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Stock Analysis

Industrial Minerals (ASX:IND) Jumps on New Gold Target — Is the Rally Backed by Solid Numbers?

The reinterpretation combined open-file aeromagnetic and gravity data with structural analysis and historical drill results, defining a discrete target rather than announcing a new discovery. Industrial Minerals believes the mineralisation may form part of a broader structurally controlled system tracking the shear zone — …

Sonal Goyal | 24 August 2026

Elixir Energy (ASX:EXR) Shares Flat Today — Does the New QGC Data Deal Change the Outlook?

While the update carries no immediateEarningsimpact, it strengthens Elixir's technical picture of its core gas appraisal acreage — a step investors often watch closely in early-stage gas plays.

Sonal Goyal | 24 August 2026

Capral (ASX:CAA) Shares Climb 1.8% on 14% Revenue Growth — Are the Fundamentals Catching Up?

Higher London Metal Exchange aluminium prices and regional premiums lifted selling prices, pushing underlying EBIT to $16.7 million from $16.1 million. It's worth noting the NPAT comparison is skewed slightly by a one-off $2.5 million tax benefit recognised in 1H25 that wasn't repeated this …

Sonal Goyal | 24 August 2026

Atomic Eagle (ASX:AUE) Stock Slips Despite Landmark Niger Uranium Deal — Is It Still Worth Watching?

The company has struck a newMiningConvention with the Republic of Niger, restoring its 60% ownership and full operational control of the Madaouela Uranium Project — ending a prolonged ownership dispute and adding a second major uranium asset to its portfolio alongside Zambia's Muntanga project.

Sonal Goyal | 24 August 2026

Adore Beauty (ASX:ABY) Shares Soar 19% on Record Revenue — Is This Just the Start of the Rally?

The market appears to be looking past this year's thin profit and focusing on the underlying growth drivers: 13 new stores opened (taking the network to 20), a new National Distribution Centre now live in Broadmeadows, a fresh ERP system, and AI tools rolled …

Sonal Goyal | 24 August 2026

CSL (ASX:CSL) Turns a Painful Reset Into a Potential Growth Recovery Story

CSL (ASX:CSL) delivered one of the most challenging headline results in its recent history, reporting a significant statutory loss due to largeImpairmentcharges. However, investors focused on the underlyingBusinessperformance, improving plasma trends, cost reductions and FY27 guidance that suggested a return toward growth. The key …

Aditi Sarkar | 24 August 2026

Cochlear (ASX:COH) Turns Investor Attention Back to Growth After a Challenging FY26

Cochlear (ASX:COH) delivered a challenging FY26 result, with lower profit and a reduced dividend, but the market focused on improving operational momentum and a more constructive FY27 outlook. The company's second-half recovery, rapid adoption of the Nucleus Nexa System and continued growth in services …

Aditi Sarkar | 24 August 2026

Pro Medicus (ASX:PME) Delivers Another Record Year as Growth, Margins and AI Ambitions Expand

Pro Medicus (ASX:PME) delivered another year of strong operational growth, supported by rising revenue, major healthcare contracts and industry-leading software margins. The company continues to expand its position in medical imaging technology, while new opportunities in reporting, artificial intelligence and adjacent healthcare areas could …

Aditi Sarkar | 24 August 2026

SCX.ai (ASX:SCX) Faces Its First Market Test After a Cool ASX Debut

SCX.ai Holdings (ASX:SCX) has entered the ASX with exposure to two of the market's most discussed themes: artificial intelligence and data sovereignty. The company's proposition centres on providing local AI computing infrastructure for organisations seeking Australian-based processing capacity. However, its early trading performance highlights …

Aditi Sarkar | 24 August 2026

EQT Holdings (ASX:EQT) Draws Two Private Equity Bids as Takeover Battle Takes Shape

EQT Holdings (ASX:EQT) has moved from a relatively quiet position in the ASX small-cap market into takeover focus after attracting interest from two private-equity bidders within days. The competing approaches highlight the strategic value of the company's regulatedTrusteeplatform, although the proposals remain preliminary and …

Aditi Sarkar | 24 August 2026
Support

Hi! How can we help you today?

Loading…